摘要
Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms of acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant prostate cancer (mCRPC). This study is made available on AWS via the NIH STRIDES Initiative.
条目元信息
- 资源编号
- AISLI-R-C322732AF447FD82C20E
- 类型
- 数据集
- 来源目录
- registry.opendata.aws
- 主题领域
- 生命科学与生物医学
- 使用条件
- NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies